Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
Condition(s):Primary Immune Deficiency DiseaseLast Updated:February 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Primary Immune Deficiency DiseaseLast Updated:February 2, 2017Completed
Condition(s):Acute Myeloid Leukemia; Relapse Leukemia; Refractory Acute Myeloid LeukemiaLast Updated:February 8, 2023Recruiting
Condition(s):Pneumonia; Urinary Tract Infections; Fall; Infections; GI Disorders; Orthopedic DisorderLast Updated:February 16, 2023Completed
Condition(s):Solid TumorLast Updated:March 6, 2024Recruiting
Condition(s):Atopic Dermatitis; Eczema; Ichthyosis VulgarisLast Updated:January 11, 2024Recruiting
Condition(s):Anesthesia; Liver Functions; Kidney Functions; GeriatricLast Updated:June 10, 2022Completed
Condition(s):Obstructive Sleep Apnea of AdultLast Updated:February 27, 2018Completed
Condition(s):Breast Cancer; NeoadjuvantLast Updated:August 21, 2023Recruiting
Condition(s):MelanomaLast Updated:February 26, 2015Completed
Condition(s):Soft Tissue SarcomaLast Updated:April 12, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.